Market Wrap / war worries

The S&P/ASX 200 rose 0.7% to 8,823 points on Monday, as investors kept a close eye on the future of the US-Iran peace deal after a report the countries had agreed to halt strikes and resume talks.  Eight out of the 11 sectors rose on the ASX with tech and healthcare sectors helping to boost the market.  Mining stocks were mixed, with weakness in gold stocks, though heavyweight BHP gained a solid 1.4%. CSL rose 0.5% despite a setback after the European Medicines Agency recommended revoking marketing authorisation for its Tavneos treatment. Neuren Pharmaceuticals jumped 36% after the European regulator recommended approving its Daybue treatment. REITs were softer over the session, with Stockland down 3.5%, although Citi said it is time to buy into the space as rates near their peak. On the M&A front, Accent Group rejected Frasers’ takeover bid at 65 cents per share, with shares closing flat at $0.71.  Overnight, a meeting of central bankers kicks off in Europe, while Collins Foods is due to report earnings tomorrow.